GRUNENTHAL GMBH, Assertio Therapeutics, Inc., Plaintiffs-Cross-Appellants
v.
ALKEM LABORATORIES LIMITED, Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc., Defendants-Appellants
Actavis Elizabeth LLC, Defendant-Appellee
Actavis Laboratories UT, Inc., Defendant.
United States Court of Appeals, Federal Circuit.https://leagle.com/images/logo.png
Decided: March 28, 2019.
Decided: March 28, 2019.
Attorney(s) appearing for the Case
Michael Sitzman , Gibson, Dunn & Crutcher LLP, San Francisco, CA, argued for all plaintiffs-cross-appellants. Plaintiff-cross-appellant Assertio Therapeutics, Inc. also represented by Jaysen Chung ; Christine Ranney , Denver, CO; Timothy P. Best , Los Angeles, CA.
Linda A. Wadler , Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, for plaintiff-cross-appellant Grunenthal GmbH. Also represented by Krista E. Bianco.
Robert J. Gajarsa , Latham & Watkins LLP, Washington, DC, argued for defendants-appellants Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. Also represented by Kenneth G. Schuler , Chicago, IL; Gregory Sobolski , San Francisco, CA.
Alkem Laboratories Limited, Hikma Pharmaceuticals International Limited, and Hikma Pharmaceuticals USA Inc. appeal the judgment of the district court that U.S. Patent No. 7,994,364 is not invalid for obviousness or lack of utility. Grünenthal GmbH and Assertio Therapeutics, Inc., formerly Depomed, Inc., cross-appeal the...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.